This article has been updated from a previous version to include comments made by Natera executives during an earnings call.

NEW YORK (GenomeWeb) – Natera reported after the close of the market Tuesday that its fourth quarter revenues grew about 9 percent year over year as the company fell short of Wall Street expectations on both the top and bottom lines.

For the three months ended Dec. 31, 2017, Natera tallied revenues of $53.8 million compared to $49.3 million a year ago. Analysts on average had expected Q4 revenues of $57.1 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.